Quarterly report pursuant to Section 13 or 15(d)

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.24.0.1
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Accounts Receivable, Allowance for Credit Loss, Current $ 85 $ 87
Common Stock, Shares Authorized Unlimited Unlimited
Common Stock, No Par Value $ 0 $ 0
Common Stock, Shares, Issued 6,459,844 6,403,289
Common Stock, Shares, Outstanding 6,459,844 6,403,289